Dr. Ravi Kiran Kaja, Ph.D., FRSC, is a senior scientific leader with 20+ years of experience in analytical chemistry and pharmaceutical R&D, specializing in sterile and complex drug products. At USP, he leads scientific strategy for complex generics and develops high impact USP–NF standards that strengthen global quality and regulatory frameworks. His expertise spans formulation analytics, E&L, and technology transfer. A collaborative leader and mentor, Dr. Kaja is dedicated to advancing pharmaceutical quality and supporting the next generation of scientists.

Rodrigo Feliciano is a Senior Principal Scientist at Johnson & Johnson, Belgium, and an E&L subject matter expert supporting regulatory strategies for complex drug–device combination products. He has 20 years of experience in analytical chemistry, including nine years focused on E&L, with expertise in chromatography and mass spectrometry. He holds a PharmD from the University of Lisbon and a PhD from the University of Wisconsin–Madison, followed by postdoctoral training in Germany. He has authored 33 peer-reviewed publications, is an active member of the ELSIE community, represents Belgium in ISO/TC 194, and is a Fulbright alumnus.

Chemical engineer with PhD (2013) in resource management and water quality; work experience in composite materials, dairy processing, blood plasma- and cell derived therapeutic proteins, and REACH regulation. Managing E&L at Octapharma since 2015.